Journal of Diagnostics Concepts & Practice ›› 2020, Vol. 19 ›› Issue (05): 534-539.doi: 10.16150/j.1671-2870.2020.05.018
• Review article • Previous Articles Next Articles
Received:2019-11-28
Online:2020-10-25
Published:2022-07-14
CLC Number:
| 分类 | 机制 |
|---|---|
| 原发性CMB | 动脉和（或）小动脉破裂, 血脑屏障破坏和（或） 毛细血管中断 |
| 继发性CMB | 出血性梗死, 出血性微梗死 |
| 假性CMB | 缺血诱导的少突胶质细胞内贮存铁的释放, 血管自噬a) |
| [1] |
Offenbacher H, Fazekas F, Schmidt R, et al. MR of cerebral abnormalities concomitant with primary intracerebral hematomas[J]. Am J Neuroradiol, 1996, 17(3):573-578.
pmid: 8881257 |
| [2] |
Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intra-cerebral hemorrhage: evidence of microangiopathy-related microbleeds[J]. Am J Neuroradiol, 1999, 20(4):637-642.
pmid: 10319975 |
| [3] | Poels MM, Vernooij MW, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study[J]. Stroke, 2010, 41(10 Suppl):S103-S106. |
| [4] |
Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting[J]. Brain, 2007, 130(Pt 8):1988-2003.
doi: 10.1093/brain/awl387 pmid: 17322562 |
| [5] |
Fisher M. Cerebral microbleeds: where are we now?[J]. Neurology, 2014, 83(15):1304-1305.
doi: 10.1212/WNL.0000000000000871 pmid: 25186856 |
| [6] |
Cheng AL, Batool S, McCreary CR, et al. Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds[J]. Stroke, 2013, 44(10):2782-2786.
doi: 10.1161/STROKEAHA.113.002267 URL |
| [7] |
Rockson SG, Albers GW. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation[J]. J Am Coll Cardiol, 2004, 43(6):929-935.
doi: 10.1016/j.jacc.2003.11.028 URL |
| [8] |
Saito T, Kawamura Y, Tanabe Y, et al. Cerebral microbleeds and asymptomatic cerebral infarctions in patients with atrial fibrillation[J]. J Stroke Cerebrovasc Dis, 2014, 23(6):1616-1622.
doi: 10.1016/j.jstrokecerebrovasdis.2014.01.005 URL |
| [9] |
European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2010, 31(19):2369-2429.
doi: 10.1093/eurheartj/ehq278 URL |
| [10] |
Dowlatshahi D, Butcher KS, Asdaghi N, et al. Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal[J]. Stroke, 2012, 43(7):1812-1817.
doi: 10.1161/STROKEAHA.112.652065 pmid: 22556194 |
| [11] |
Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation[J]. Lancet Neurol, 2009, 8(2):165-174.
doi: 10.1016/S1474-4422(09)70013-4 pmid: 19161908 |
| [12] |
Lovelock CE, Cordonnier C, Naka H, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies[J]. Stroke, 2010, 41(6):1222-1228.
doi: 10.1161/STROKEAHA.109.572594 URL |
| [13] |
Jeon SB, Kang DW, Cho AH, et al. Initial microbleeds at MR imaging can predict recurrent intracerebral hemorrhage[J]. J Neurol, 2007, 254(4):508-512.
doi: 10.1007/s00415-006-0406-6 URL |
| [14] |
Imaizumi T, Inamura S, Nomura T. Contribution of deep microbleeds to stroke recurrence: differences between patients with past deep intracerebral hemorrhages and lacunar infarctions[J]. J Stroke Cerebrovasc Dis, 2015, 24(8):1855-1864.
doi: 10.1016/j.jstrokecerebrovasdis.2015.04.027 pmid: 25980343 |
| [15] |
Vermeer SE, Algra A, Franke CL, et al. Long-term prognosis after recovery from primary intracerebral hemorrhage[J]. Neurology, 2002, 59(2):205-209.
pmid: 12136058 |
| [16] |
Charidimou A, Kakar P, Fox Z, et al. Cerebral micro-bleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts[J]. Stroke, 2013, 44(4):995-1001.
doi: 10.1161/STROKEAHA.111.000038 pmid: 23493732 |
| [17] |
Wilson D, Charidimou A, Ambler G, et al. Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: a meta-analysis[J]. Neurology, 2016, 87(14):1501-1510.
doi: 10.1212/WNL.0000000000003183 URL |
| [18] |
Akoudad S, Portegies ML, Koudstaal PJ, et al. Cerebral microbleeds are associated with an increased risk of stroke: the rotterdam study[J]. Circulation, 2015, 132(6):509-516.
doi: 10.1161/CIRCULATIONAHA.115.016261 pmid: 26137955 |
| [19] |
Charidimou A, Karayiannis C, Song TJ, et al. Brain microbleeds, anticoagulation, and hemorrhage risk: meta-analysis in stroke patients with AF[J]. Neurology, 2017, 89(23):2317-2326.
doi: 10.1212/WNL.0000000000004704 pmid: 29117953 |
| [20] |
Song TJ, Kim J, Song D, et al. Association of cerebral microbleeds with mortality in stroke patients having atrial fibrillation[J]. Neurology, 2014, 83(15):1308-1315.
doi: 10.1212/WNL.0000000000000862 URL |
| [21] |
Eckman MH, Wong LK, Soo YO, et al. Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics and imaging help?[J]. Stroke, 2008, 39(12):3308-3315.
doi: 10.1161/STROKEAHA.108.523159 pmid: 18845797 |
| [22] |
Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation[J]. N Engl J Med, 2009, 361(12):1139-1151.
doi: 10.1056/NEJMoa0905561 URL |
| [23] |
Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation[J]. N Engl J Med, 2011, 365(11):981-992.
doi: 10.1056/NEJMoa1107039 URL |
| [24] |
Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation[J]. N Engl J Med, 2011, 365(10):883-891.
doi: 10.1056/NEJMoa1009638 URL |
| [25] |
Cervera A, Amaro S, Chamorro A. Oral anticoagulant-associated intracerebral hemorrhage[J]. J Neurol, 2012, 259(2):212-224.
doi: 10.1007/s00415-011-6153-3 pmid: 21748282 |
| [26] |
Eckman MH, Rosand J, Knudsen KA, et al. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis[J]. Stroke, 2003, 34(7):1710-1716.
pmid: 12805495 |
| [27] |
Greenberg SM, Eng JA, Ning M, et al. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage[J]. Stroke, 2004, 35(6):1415-1420.
pmid: 15073385 |
| [28] |
Kuramatsu JB, Gerner ST, Schellinger PD, et al. Anticoa-gulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intra-cerebral hemorrhage[J]. JAMA, 2015, 313(8):824-836.
doi: 10.1001/jama.2015.0846 pmid: 25710659 |
| [29] |
Passero S, Burgalassi L, D'Andrea P, et al. Recurrence of bleeding in patients with primary intracerebral hemorrhage[J]. Stroke, 1995, 26(7):1189-1192.
pmid: 7604411 |
| [30] |
Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2015, 46(7):2032-2060.
doi: 10.1161/STR.0000000000000069 pmid: 26022637 |
| [31] |
Wilson D, Jäger HR, Werring DJ. Anticoagulation for atrial fibrillation in patients with cerebral microbleeds[J]. Curr Atheroscler Rep, 2015, 17(8):47.
doi: 10.1007/s11883-015-0524-7 URL |
| [32] |
Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review[J]. Neurology, 2007, 69(6):546-554.
doi: 10.1212/01.wnl.0000267275.68538.8d URL |
| [33] |
Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas[J]. Stroke, 2005, 36(7):1588-1593.
doi: 10.1161/01.STR.0000170642.39876.f2 URL |
| [34] |
Song TJ, Kim J, Lee HS, et al. The frequency of cerebral microbleeds increases with CHADS(2) scores in stroke patients with non-valvular atrial fibrillation[J]. Eur J Neurol, 2013, 20(3):502-508.
doi: 10.1111/ene.12003 pmid: 23057579 |
| [35] |
Wilson D, Ambler G, Shakeshaft C, et al. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study[J]. Lancet Neurol, 2018, 17(6):539-547.
doi: 10.1016/S1474-4422(18)30145-5 URL |
| [36] |
Soo Y, Abrigo JM, Leung KT, et al. Risk of intracerebral whaemorrhage in Chinese patients with atrial fibrillation on warfarin with cerebral microbleeds: the IPAAC-warfarin study[J]. J Neurol Neurosurg Psychiatry, 2019, 90(4):428-435.
doi: 10.1136/jnnp-2018-319104 URL |
| [37] |
Wilson D, Charidimou A, Ambler G, et al. Recurrent stroke risk and cerebral microbleed burden in ischemic stroke and TIA: a meta-analysis[J]. Neurology, 2016, 87(14):1501-1510.
doi: 10.1212/WNL.0000000000003183 URL |
| [38] |
Selim M, Diener HC. Atrial fibrillation and microbleeds[J]. Stroke, 2017, 48(10):2660-2664.
doi: 10.1161/STROKEAHA.117.017085 URL |
| [39] |
Lip GY, Andreotti F, Fauchier L, et al. Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis[J]. Europace, 2011, 13(5):723-746.
doi: 10.1093/europace/eur126 URL |
| [40] |
Hylek EM, Evans-Molina C, Shea C, et al. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation[J]. Circulation, 2007, 115(21):2689-2696.
doi: 10.1161/CIRCULATIONAHA.106.653048 URL |
| [41] |
Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey[J]. Chest, 2010, 138(5):1093-1100.
doi: 10.1378/chest.10-0134 pmid: 20299623 |
| [42] |
Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials[J]. Lancet, 2014, 383(9921):955-962.
doi: 10.1016/S0140-6736(13)62343-0 URL |
| [43] |
Lee SH, Ryu WS, Roh JK. Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage[J]. Neurology, 2009, 72(2):171-176.
doi: 10.1212/01.wnl.0000339060.11702.dd URL |
| [44] |
Saito T, Kawamura Y, Sato N, et al. Non-vitamin K anta-gonist oral anticoagulants do not increase cerebral micro-bleeds[J]. J Stroke Cerebrovasc Dis, 2015, 24(6):1373-1377.
doi: 10.1016/j.jstrokecerebrovasdis.2015.02.018 URL |
| [45] |
Fisher M. MRI screening for chronic anticoagulation in atrial fibrillation[J]. Front Neurol, 2013, 4:137.
doi: 10.3389/fneur.2013.00137 pmid: 24109470 |
| [46] |
Wang Z, Soo YO, Mok VC. Cerebral microbleeds: is antithrombotic therapy safe to administer?[J]. Stroke, 2014, 45(9):2811-2817.
doi: 10.1161/STROKEAHA.114.004286 URL |
| [47] | Smith EE, Saposnik G, Biessels GJ, et al. Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2017, 48:e44-e71. |
| [48] |
Microbleeds International Collaborative Network. Worldwide collaboration in the Microbleeds International Collaborative Network[J]. Lancet Neurol, 2016, 15(11):1113-1114.
doi: 10.1016/S1474-4422(16)30213-7 URL |
| [49] |
Charidimou A, Soo Y, Heo JH, et al. A call for researchers to join the META-MICROBLEEDS Consortium[J]. Lancet Neurol, 2016, 15(9):900.
doi: S1474-4422(16)30124-7 pmid: 27478945 |
| [1] | WU Dongdong, CHEN Yuhui, LIU Fang, LIU Yinhong, JIANG Jingwen. Study progress on cerebral small vessel disease complicated with neurodegenerative disorders in central nervous system [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(05): 644-649. |
| [2] | SONG Luoqing, DAI Tingjun. Primary antiphospholipid syndrome complicated with moyamoya syndrome: a case report and literature review [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 497-503. |
| [3] | LIANG Yali, ZHAO Haigang, XIANG Guangyu. The stress-induced hyperglycemia ratio in the prognosis prediction of patients with acute ischemic stroke one year after thrombolytic therapy [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(06): 562-566. |
| [4] | ZHAO Zongbo, JIA Chuanhai, LIU Hui. Application of arterial spin labeling magnetic resonance perfusion imaging (MRI-ASL) combined with magnetic resonance angiography (MRA) for the prediction of progress of posterior circulation ischemic (PCI) stroke [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(04): 412-417. |
| [5] | CHEN Jie, HU Jin, YANG Kang, FU Yi. Analysis of risk factors and prognosis of cerebral hemorrhage patients accompanied by cortical superficial siderosis [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(2): 133-138. |
| [6] | . [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(04): 368-372. |
| [7] | JI Haifeng, YANG Xuelian, YAO Yulan, CAI Liying, LAI Xiaoyin, WU Dayu, XU Yumei, JIANG Mei. Validation of mSORE score for predicting poor outcome in acute ischemic stroke [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(04): 423-427. |
| [8] | . [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 344-346. |
| [9] | HU Rongguo, PANG Defang, HUANG Shu, SHEN Zhenkun, CHEN Wei, YANG Yuwei, LAI Xiaoyin, ZHU Wei, WU Feifei, JI Haifeng, WU Dayu, JIANG Mei, SUN Jialan, LI Longxuan. Correlation of plasma miRNAs levels with atrial fibrillation in patients with acute cerebral infarction in early stage [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(01): 98-103. |
| [10] | MU Jinjin, YANG Kang, FENG Yulan, FU Yi. New silent cerebral infarction in patients with hypertensive intracerebral hemorrhage: related risk factors and prognosis [J]. Journal of Diagnostics Concepts & Practice, 2016, 15(05): 492-497. |
| [11] | MAIMAITI Yiming, RE Xidan, CHEN Bo, ZHANG Xiang, MA Weiying, YANG Kang, FU Yi. Analysis on relationship between polymorphism of chromosome region 9p21 and susceptibility of carotid plaque in acute non-cardioembolic cerebral infarction patients [J]. Journal of Diagnostics Concepts & Practice, 2016, 15(05): 498-502. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
